Physician profile
Charles D Cibula
NPI 1750590246
$37,777.04
in general payments reported to CMS, 2019-2025
34 companies · $2,879 in 2025
The $2,879 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,674 · 2020: $1,135 · 2021: $12K · 2022: $4,653 · 2023: $6,614 · 2024: $2,642 · 2025: $2,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,621 · Travel and Lodging: $4,974 · Education: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,620.62 |
| Travel and Lodging | $4,974.04 |
| Education | $540.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,130.44 | 2019-2025 | Prostep, Prophecy, Inbone |
| Wardlow Enterprises | $7,188.48 | 2019-2023 | |
| Arthrex, INC. | $5,970.58 | 2019-2021 | |
| Trilliant Surgical LLC. | $1,901.30 | 2019 | |
| Exactech, INC. | $862.34 | 2021 | |
| International Life Sciences | $813.61 | 2024 | Flexband |
| Depuy Synthes Sales INC. | $612.02 | 2019-2024 | Motoband |
| Smith+Nephew, INC. | $386.50 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Grafix Pl |
| Organogenesis INC. | $373.35 | 2019-2025 | Puraply, Novachor, Simplimax |
| Treace Medical Concepts, INC. | $327.34 | 2023-2025 | |
| Abbvie INC. | $157.67 | 2022-2025 | Dalvance |
| Wright Medical Technology, INC. | $121.92 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $96.14 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $94.38 | 2025 | |
| Prism Medical | $87.26 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $74.02 | 2025 | Magnetos |
| Horizon Therapeutics Plc | $72.64 | 2020-2023 | Krystexxa |
| Medshape, INC. | $65.53 | 2024 | Dynanail Helix, Washer, 15 Mm, Lapidus Correction Jig, Right |
| Novastep INC. | $55.89 | 2024 | Nexis |
| Next Science LLC | $47.74 | 2020 | |
| Convatec INC. | $46.18 | 2024-2025 | |
| Djo, LLC | $45.10 | 2023 | Cmf |
| Davol INC. | $38.63 | 2025 | Surgiphor |
| Medela LLC | $29.71 | 2020 | |
| Zimmer Biomet Holdings, INC. | $28.76 | 2020-2021 | |
| Integra Lifesciences Corporation | $26.55 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $20.63 | 2024 | Nuzyra |
| Amgen INC. | $19.06 | 2024 | Krystexxa |
| Allergan, INC. | $18.22 | 2020 | |
| Encore Medical, LP | $16.27 | 2024 | Djo Surgical |
| Heron Therapeutics, INC. | $13.86 | 2022 | |
| Osiris Therapeutics INC. | $13.60 | 2019 | |
| Kerecis Limited | $12.85 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthofix Medical, INC. | $8.47 | 2019-2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cibula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.